Analysis

Xencor, Inc. (XNCR) Stock Analysis

Xencor, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to XNCR.

websiteXNCR/analysis/XNCR

Xencor, Inc.

Xencor, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to XNCR.

Stock profile

Ticker

XNCR

Asset type

Stock

Market cap

$937.1M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Xencor, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • XNCR primary listing
  • XE9
  • A1W96L

Latest Xencor, Inc. news

Xencor Reports First Quarter 2026 Financial Results

-- XmAb819 clear cell renal cell carcinoma (ccRCC) expansion cohort results to be presented at a medical conference in 2H26 -- -- XmAb412 (TL1A x IL23p19)

Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW

PASADENA, Calif., May 04, 2026--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmun...

Xencor Announces Change to Ultomiris® Royalty Revenue Forecast

PASADENA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment

Xencor Reports Fourth Quarter and Full Year 2025 Financial Results

-- XmAb819, novel first-in-class ENPP3 x CD3 T-cell engaging bispecific antibody, Phase 1 dose expansion in CRC, NSCLC and pRCC open to enrollment; on track

Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones

PASADENA, Calif., January 08, 2026--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoi...

Research sections

Valuation

Review valuation context for Xencor, Inc..

Future growth

Review future growth context for Xencor, Inc..

Past performance

Review past performance context for Xencor, Inc..

Financial health

Review financial health context for Xencor, Inc..

Dividend

Review dividend context for Xencor, Inc..

Management

Review management context for Xencor, Inc..

Ownership

Review ownership context for Xencor, Inc..

Other information

Review other information context for Xencor, Inc..

Community

Review community context for Xencor, Inc..